SCHEMBL8350786

SCHEMBL8350786

Cc1ccc(C(C)(C)CN2CCNCC2=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.38
KMT2A Q03164 4/20 0.36
RAB9A P51151 1/20 0.36
ADRB1 P08588 1/20 0.36
TP53 P04637 1/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.33
RECQL P46063 1/20 0.33
HSD11B1 P28845 1/20 0.32
MEN1 O00255 3/20 0.32
CXCR4 P61073 1/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
GAA P10253 1/20 0.32
TSHR P16473 1/20 0.32
LMNA P02545 1/20 0.31
GPR4 P46093 1/20 0.31
KCNH2 Q12809 1/20 0.31
SLC6A9 P48067 1/20 0.30
MMP2 P08253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14347760 0.81 SMN1; SMN2 (0.51) SMN1; SMN2KMT2ARAB9ATP53ALDH1A1
SCHEMBL8350850 0.78 PER2 (0.46) KMT2ARAB9ATP53ALDH1A1MEN1
SCHEMBL14347756 0.77 PER2 (0.47) SMN1; SMN2KMT2ARAB9AALDH1A1MEN1
SCHEMBL12125492 0.76 USP19 (0.31)
Bromide SCHEMBL28429290 0.75 USP19 (0.30)
SCHEMBL14347751 0.74 PER2 (0.46) SMN1; SMN2KMT2ARAB9ATP53ALDH1A1
SCHEMBL8351476 0.74 KMT2A (0.37) SMN1; SMN2KMT2ARAB9AADRB1ALDH1A1
SCHEMBL22248562 0.73 F10 (0.31)
SCHEMBL8353184 0.70 SMN1; SMN2 (0.38) SMN1; SMN2KMT2ARAB9AADRB1TP53
SCHEMBL3635000 0.70 P2RX7 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 WO disclosed